Skip to main content

Table 4 The top ten significantly enriched pathways of targeted ribosomal proteins in the predicted PPI, based on DAVID and KOBAS analysis

From: In silico evidence of de novo interactions between ribosomal and Epstein - Barr virus proteins

Platform

Pathway database

Pathway names

p-value

DAVID

KEGG

Ribosome

2.68e-43

Reactome

3′ -UTR-mediated translational regulation

2.07e-41

Reactome

Influenza Infection

8.22e-37

Reactome

Metabolism of proteins

6.79e-33

Reactome

Gene Expression

3.96e-27

Reactome

APC-Cdc20 mediated degradation of Nek2A

0.002563

Reactome

Regulation of activated PAK-2p34 by proteasome mediated degradation

0.014244

Reactome

Signaling by EGFR

0.014717

Reactome

APC/C: Cdh1-mediated degradation of Skp2

0.026468

Reactome

Signaling by Wnt

0.026468

KOBAS

Reactome

Viral mRNA Translation

4.96e-55

Reactome

Peptide chain elongation

4.96e-55

Reactome

Selenocysteine synthesis

5.58e-55

Reactome

Eukaryotic Translation Elongation

6.99e-55

Reactome

Eukaryotic Translation Termination

7.83e-55

Reactome

Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)

1.26e-54

Reactome

Formation of a pool of free 40S subunits

2.05e-54

Reactome

L13a-mediated translational silencing of Ceruloplasmin expression

1.50e-53

Reactome

GTP hydrolysis and joining of the 60S ribosomal subunit

1.61e-53

Reactome

Nonsense-Mediated Decay (NMD)

3.61e-53